New York, New York–(Newsfile Corp. – May 19, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American:Read More

You might also be interested in reading Biggest Movers: BNB Snaps Losing Streak, Surging Back Above $240.